论文部分内容阅读
癌症病人的肿瘤类型、病期、体重丢失和活动状况是主要预后因素,而体重丢失最有可能进行治疗或预防。体重丢失是恶性病最常见的全身不利反应。癌病人体重丢失的发生率,从非何杰金氏淋巴瘤的30%到胃癌的90%,常与肿瘤类型有关,胰和胃癌最为严重。体表肿瘤可早期发现,体重丢失较轻,如肿瘤已到只能姑息治疗阶段,几乎所有病人均有明显体重丢失。体重丢失病人比未丢失者生存期要短,某些肿瘤(肉瘤、淋巴瘤、结肠癌及前列腺癌)
Tumor type, stage, weight loss, and activity of cancer patients are the main prognostic factors, and weight loss is most likely to be treated or prevented. Loss of body weight is the most common systemic adverse reaction of malignancy. The incidence of weight loss in cancer patients, from 30% of non-Hodgkin’s lymphoma to 90% of gastric cancer, is often related to the type of tumor, pancreatic and gastric cancer is the most serious. Body surface tumors can be found early, and weight loss is lighter. If the tumor has reached the stage of palliative treatment, almost all patients have significant weight loss. Loss-of-weight patients have a shorter survival period than non-lost patients, some tumors (sarcoma, lymphoma, colon and prostate cancer)